Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before.

Ultralife's revenue has been volatile in the past decade or so, but its recent comeback seems to have more legroom to grow. See why ULBI stock is a Buy.

Roku maintains a net cash balance sheet and is projecting GAAP profitability over the coming year. Find out why ROKU stock is ...

For 1Q25, Macquarie Wealth Builder Fund Institutional Class shares declined but outperformed the Fund's benchmark. Click here ...

China's Zijin Mining (ZIJMF), one of the country's largest miners of gold and copper, has struck a deal to buy a project in Kazakhstan, the Raygorodok Gold Mine, for $1.2 billion.

PDD Holdings faces headwinds, but profitability remains robust. Read why I reiterate Buy on PDD stock, despite recent ...

Vallourec (VLOUF) has secured a significant order from Abu Dhabi National Oil Company (ADNOC) for the supply of more than 30,000 tons of carbon steel tubulars and associated accessories featuring VAM ...

The Bancorp's shares are attractively priced on earnings, though expensive on book value. Learn why TBBK stock is a Buy.

Corcept's main revenue driver, Korlym, helps treat hyperglycemia in adults with Cushing's Syndrome. Read why I rate CORT ...

Toyota Motor maintains its position as the leading vehicle seller and revenue growth leader. Find out why TM stock is a Buy.

Thrivent Short-Term Bond Fund outperformed the Bloomberg U.S. Government/Credit 1-3 Year Bond Index by 0.03%. Read more here.

Thrivent Municipal Bond Fund underperformed the Bloomberg Municipal Bond Index by -.73% in the first quarter of 2025. For the ...